SUNNYVALE, Calif.--(BUSINESS WIRE)--Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced the successful treatment of the first series of patients in the United States with the HeliFXTM Aortic Securement System after having received FDA clearance on Nov. 21. The innovative helical anchor technology enables independent endograft fixation to the aorta, and is designed to mimic the hand suturing performed during open surgical repair of abdominal aortic aneurysms (AAAs). In the first few weeks since regulatory clearance, physicians have already used the HeliFX System in both de novo (initial) EVAR procedures as well as in secondary interventions, and with several different manufacturers’ endografts – all in cases where the physicians believed that long term patient outcomes would be improved with augmented fixation and sealing of the endograft with the HeliFX EndoAnchorsTM.
